Clinical Trial Update: Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas [Phase 2]

View source ↗

Summary

Phase 2 trial investigating autologous dendritic cells loaded with autologous tumor-associated antigens for advanced epithelial ovarian carcinomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Epithelial Cancer
• Peritoneal Cancer

Drugs mentioned

• Autologous dendritic cells loaded with autologous tumor associated antigens

Snippet

Sponsor: Aivita Biomedical, Inc. | Conditions: Stage III Ovarian Carcinoma, Stage IV Ovarian Carcinoma | Phase 2 | Status: UNKNOWN